1. Home
  2. HXL vs ADMA Comparison

HXL vs ADMA Comparison

Compare HXL & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hexcel Corporation

HXL

Hexcel Corporation

HOLD

Current Price

$73.39

Market Cap

5.0B

Sector

Industrials

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$19.71

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HXL
ADMA
Founded
1946
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
4.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HXL
ADMA
Price
$73.39
$19.71
Analyst Decision
Buy
Strong Buy
Analyst Count
8
2
Target Price
$72.88
$28.50
AVG Volume (30 Days)
1.3M
2.9M
Earning Date
01-21-2026
11-05-2025
Dividend Yield
0.93%
N/A
EPS Growth
N/A
205.35
EPS
0.84
0.86
Revenue
$1,876,400,000.00
$488,559,000.00
Revenue This Year
$0.16
$22.19
Revenue Next Year
$10.49
$24.33
P/E Ratio
$86.65
$23.11
Revenue Growth
N/A
27.63
52 Week Low
$45.28
$13.50
52 Week High
$79.20
$25.67

Technical Indicators

Market Signals
Indicator
HXL
ADMA
Relative Strength Index (RSI) 50.64 65.11
Support Level $71.98 $19.13
Resistance Level $79.20 $20.46
Average True Range (ATR) 1.85 0.68
MACD -0.52 -0.01
Stochastic Oscillator 19.53 65.34

Price Performance

Historical Comparison
HXL
ADMA

About HXL Hexcel Corporation

Founded in 1948, Hexcel designs and manufactures a range of highly engineered composite fibers, fabrics, resins, and structures for use in the commercial aerospace, defense, and high-performance automotive markets. These are lighter than metal and perform under rigorous conditions in aircraft frames, wings, engines, and other components and subassemblies. The company's name derives from the six-sided honeycomb structures that lend many of its products their light weight and rigidity. Hexcel's biggest customers are Airbus (40% of 2024 sales) and Boeing (15% of 2024 sales; 25% before the pandemic) and their respective subcontractors.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: